Concepedia

S. Gail Eckhardt

SG

38

Publications

2.7K

Citations

28

H-Index

1994

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

University of Colorado Denver

Livestrong Foundation

Brooke Army Medical Center

University of Colorado Anschutz Medical Campus

S. Gail Eckhardt is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

1994–2020

38

Publications

38

Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer

Roy S. Herbst, S. Gail Eckhardt, Razelle Kurzrock et al. · Journal of Clinical Oncology · 2010 · 437 citations

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

Mace L. Rothenberg, John R. Eckardt, John G. Kuhn et al. · Journal of Clinical Oncology · 1996 · 351 citations

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

Jennifer Schlegel, Maria J. Sambade, Susan Sather et al. · Journal of Clinical Investigation · 2013 · 142 citations · Full text

, , +11

Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies

Lisa A. Hammond, John R. Eckardt, Sharyn D. Baker et al. · Journal of Clinical Oncology · 1999 · 132 citations

A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.

Amita Patnaik, Eric K. Rowinsky, Miguel A. Villalona et al. · PubMed · 2002 · 124 citations

, , +16

Rows per page

1–5 of 38